ロード中...
Breast Cancer Immunotherapy: Facts and Hopes
Immunotherapy is revolutionizing the management of multiple solid tumors, and early data have revealed the clinical activity of PD-1/PD-L1 antagonists in small numbers of metastatic breast cancer patients. Clinical activity appears more likely if the tumor is triple negative, PD-L1+, and/or harbors...
保存先:
| 出版年: | Clin Cancer Res |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5796849/ https://ncbi.nlm.nih.gov/pubmed/28801472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-3001 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|